HEADER IMMUNE SYSTEM 12-MAR-15 4YP1 TITLE MISTING WITH CDA COMPND MOL_ID: 1; COMPND 2 MOLECULE: STIMULATOR OF INTERFERON GENES PROTEIN; COMPND 3 CHAIN: A, B; COMPND 4 FRAGMENT: UNP RESIDUES 138-344; COMPND 5 SYNONYM: MSTING,ENDOPLASMIC RETICULUM INTERFERON STIMULATOR,ERIS, COMPND 6 MEDIATOR OF IRF3 ACTIVATION,MMITA,TRANSMEMBRANE PROTEIN 173; COMPND 7 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: MUS MUSCULUS; SOURCE 3 ORGANISM_COMMON: MOUSE; SOURCE 4 ORGANISM_TAXID: 10090; SOURCE 5 GENE: TMEM173, ERIS MITA, MPYS, STING; SOURCE 6 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 562 KEYWDS MSTING, CDA, IMMUNE SYSTEM EXPDTA X-RAY DIFFRACTION AUTHOR K.H.CHIN,C.K.CHEN,Z.I.TU,S.H.CHOU REVDAT 2 20-MAR-24 4YP1 1 COMPND JRNL REMARK HETNAM REVDAT 1 07-OCT-15 4YP1 0 JRNL AUTH K.H.CHIN,J.M.LIANG,J.G.YANG,M.S.SHIH,Z.L.TU,Y.C.WANG, JRNL AUTH 2 X.H.SUN,N.J.HU,Z.X.LIANG,J.M.DOW,R.P.RYAN,S.H.CHOU JRNL TITL STRUCTURAL INSIGHTS INTO THE DISTINCT BINDING MODE OF CYCLIC JRNL TITL 2 DI-AMP WITH SACPAA_RCK. JRNL REF BIOCHEMISTRY V. 54 4936 2015 JRNL REFN ISSN 0006-2960 JRNL PMID 26171638 JRNL DOI 10.1021/ACS.BIOCHEM.5B00633 REMARK 2 REMARK 2 RESOLUTION. 2.65 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : CNS REMARK 3 AUTHORS : BRUNGER,ADAMS,CLORE,DELANO,GROS,GROSSE- REMARK 3 : KUNSTLEVE,JIANG,KUSZEWSKI,NILGES,PANNU, REMARK 3 : READ,RICE,SIMONSON,WARREN REMARK 3 REMARK 3 REFINEMENT TARGET : ENGH & HUBER REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.65 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 50.00 REMARK 3 DATA CUTOFF (SIGMA(F)) : 2.000 REMARK 3 DATA CUTOFF HIGH (ABS(F)) : NULL REMARK 3 DATA CUTOFF LOW (ABS(F)) : NULL REMARK 3 COMPLETENESS (WORKING+TEST) (%) : 94.6 REMARK 3 NUMBER OF REFLECTIONS : 12171 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : NONE REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING SET) : 0.210 REMARK 3 FREE R VALUE : 0.260 REMARK 3 FREE R VALUE TEST SET SIZE (%) : NULL REMARK 3 FREE R VALUE TEST SET COUNT : 502 REMARK 3 ESTIMATED ERROR OF FREE R VALUE : NULL REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : NULL REMARK 3 BIN RESOLUTION RANGE HIGH (A) : NULL REMARK 3 BIN RESOLUTION RANGE LOW (A) : NULL REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : NULL REMARK 3 REFLECTIONS IN BIN (WORKING SET) : NULL REMARK 3 BIN R VALUE (WORKING SET) : NULL REMARK 3 BIN FREE R VALUE : NULL REMARK 3 BIN FREE R VALUE TEST SET SIZE (%) : NULL REMARK 3 BIN FREE R VALUE TEST SET COUNT : NULL REMARK 3 ESTIMATED ERROR OF BIN FREE R VALUE : NULL REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 2900 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 44 REMARK 3 SOLVENT ATOMS : 54 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : NULL REMARK 3 MEAN B VALUE (OVERALL, A**2) : NULL REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : NULL REMARK 3 B22 (A**2) : NULL REMARK 3 B33 (A**2) : NULL REMARK 3 B12 (A**2) : NULL REMARK 3 B13 (A**2) : NULL REMARK 3 B23 (A**2) : NULL REMARK 3 REMARK 3 ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM LUZZATI PLOT (A) : NULL REMARK 3 ESD FROM SIGMAA (A) : NULL REMARK 3 LOW RESOLUTION CUTOFF (A) : NULL REMARK 3 REMARK 3 CROSS-VALIDATED ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM C-V LUZZATI PLOT (A) : NULL REMARK 3 ESD FROM C-V SIGMAA (A) : NULL REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES. REMARK 3 BOND LENGTHS (A) : NULL REMARK 3 BOND ANGLES (DEGREES) : NULL REMARK 3 DIHEDRAL ANGLES (DEGREES) : NULL REMARK 3 IMPROPER ANGLES (DEGREES) : NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL MODEL : NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. RMS SIGMA REMARK 3 MAIN-CHAIN BOND (A**2) : NULL ; NULL REMARK 3 MAIN-CHAIN ANGLE (A**2) : NULL ; NULL REMARK 3 SIDE-CHAIN BOND (A**2) : NULL ; NULL REMARK 3 SIDE-CHAIN ANGLE (A**2) : NULL ; NULL REMARK 3 REMARK 3 BULK SOLVENT MODELING. REMARK 3 METHOD USED : NULL REMARK 3 KSOL : NULL REMARK 3 BSOL : NULL REMARK 3 REMARK 3 NCS MODEL : NULL REMARK 3 REMARK 3 NCS RESTRAINTS. RMS SIGMA/WEIGHT REMARK 3 GROUP 1 POSITIONAL (A) : NULL ; NULL REMARK 3 GROUP 1 B-FACTOR (A**2) : NULL ; NULL REMARK 3 REMARK 3 PARAMETER FILE 1 : NULL REMARK 3 TOPOLOGY FILE 1 : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 4YP1 COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBJ ON 20-MAR-15. REMARK 100 THE DEPOSITION ID IS D_1000207854. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 23-APR-13 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 8.0 REMARK 200 NUMBER OF CRYSTALS USED : 8 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : NSRRC REMARK 200 BEAMLINE : BL13B1 REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1.0000 REMARK 200 MONOCHROMATOR : NA REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : ADSC QUANTUM 315R REMARK 200 INTENSITY-INTEGRATION SOFTWARE : HKL-2000 REMARK 200 DATA SCALING SOFTWARE : HKL-2000 REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 12171 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.650 REMARK 200 RESOLUTION RANGE LOW (A) : 50.000 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : 2.000 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 94.6 REMARK 200 DATA REDUNDANCY : 6.100 REMARK 200 R MERGE (I) : NULL REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 11.9000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.65 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.78 REMARK 200 COMPLETENESS FOR SHELL (%) : 94.6 REMARK 200 DATA REDUNDANCY IN SHELL : NULL REMARK 200 R MERGE FOR SHELL (I) : NULL REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : NULL REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: CNS REMARK 200 STARTING MODEL: NULL REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 37.81 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 1.98 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 100MM TRIS 8.0, PEG 3350 20%, VAPOR REMARK 280 DIFFUSION, SITTING DROP, PH 8.0, TEMPERATURE 298K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 2 21 21 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 X,-Y,-Z REMARK 290 3555 -X,Y+1/2,-Z+1/2 REMARK 290 4555 -X,-Y+1/2,Z+1/2 REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY1 3 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 24.10400 REMARK 290 SMTRY3 3 0.000000 0.000000 -1.000000 86.21000 REMARK 290 SMTRY1 4 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 24.10400 REMARK 290 SMTRY3 4 0.000000 0.000000 1.000000 86.21000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: DIMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: DIMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 3660 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 15750 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -14.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 SER A 135 REMARK 465 ASN A 136 REMARK 465 ALA A 137 REMARK 465 LEU A 138 REMARK 465 THR A 139 REMARK 465 PRO A 140 REMARK 465 ALA A 141 REMARK 465 GLU A 142 REMARK 465 VAL A 143 REMARK 465 SER A 144 REMARK 465 ALA A 145 REMARK 465 VAL A 146 REMARK 465 CYS A 147 REMARK 465 GLU A 148 REMARK 465 GLU A 149 REMARK 465 LYS A 150 REMARK 465 LYS A 151 REMARK 465 LEU A 152 REMARK 465 THR A 317 REMARK 465 ASP A 318 REMARK 465 GLY A 319 REMARK 465 ASN A 320 REMARK 465 SER A 321 REMARK 465 GLU A 336 REMARK 465 LYS A 337 REMARK 465 GLU A 338 REMARK 465 GLU A 339 REMARK 465 VAL A 340 REMARK 465 THR A 341 REMARK 465 MET A 342 REMARK 465 ASN A 343 REMARK 465 ALA A 344 REMARK 465 SER B 135 REMARK 465 ASN B 136 REMARK 465 ALA B 137 REMARK 465 LEU B 138 REMARK 465 THR B 139 REMARK 465 PRO B 140 REMARK 465 ALA B 141 REMARK 465 GLU B 142 REMARK 465 VAL B 143 REMARK 465 SER B 144 REMARK 465 ALA B 145 REMARK 465 VAL B 146 REMARK 465 CYS B 147 REMARK 465 GLU B 148 REMARK 465 GLU B 149 REMARK 465 LYS B 150 REMARK 465 LYS B 151 REMARK 465 LEU B 152 REMARK 465 GLU B 335 REMARK 465 GLU B 336 REMARK 465 LYS B 337 REMARK 465 GLU B 338 REMARK 465 GLU B 339 REMARK 465 VAL B 340 REMARK 465 THR B 341 REMARK 465 MET B 342 REMARK 465 ASN B 343 REMARK 465 ALA B 344 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CLOSE CONTACTS IN SAME ASYMMETRIC UNIT REMARK 500 REMARK 500 THE FOLLOWING ATOMS ARE IN CLOSE CONTACT. REMARK 500 REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI DISTANCE REMARK 500 O PHE A 268 OG SER A 271 2.16 REMARK 500 OE2 GLU A 335 O HOH A 501 2.18 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 TYR A 166 -67.72 -154.81 REMARK 500 LEU A 189 49.37 -86.72 REMARK 500 ARG A 195 37.62 -97.27 REMARK 500 ARG A 221 -66.06 -106.77 REMARK 500 ALA A 232 45.73 39.74 REMARK 500 PRO A 252 92.33 -68.65 REMARK 500 PHE A 278 163.85 62.30 REMARK 500 TYR B 166 -67.92 -153.15 REMARK 500 ARG B 195 36.67 -84.14 REMARK 500 PHE B 201 75.88 -119.91 REMARK 500 CYS B 205 14.30 59.04 REMARK 500 ARG B 221 -71.41 -103.57 REMARK 500 PRO B 252 109.94 -59.40 REMARK 500 PHE B 278 139.26 46.31 REMARK 500 ASN B 307 -35.75 -133.99 REMARK 500 REMARK 500 REMARK: NULL REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue 2BA A 401 REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 4M9Z RELATED DB: PDB REMARK 900 RELATED ID: 4YP2 RELATED DB: PDB DBREF 4YP1 A 138 344 UNP Q3TBT3 STING_MOUSE 138 344 DBREF 4YP1 B 138 344 UNP Q3TBT3 STING_MOUSE 138 344 SEQADV 4YP1 SER A 135 UNP Q3TBT3 EXPRESSION TAG SEQADV 4YP1 ASN A 136 UNP Q3TBT3 EXPRESSION TAG SEQADV 4YP1 ALA A 137 UNP Q3TBT3 EXPRESSION TAG SEQADV 4YP1 SER B 135 UNP Q3TBT3 EXPRESSION TAG SEQADV 4YP1 ASN B 136 UNP Q3TBT3 EXPRESSION TAG SEQADV 4YP1 ALA B 137 UNP Q3TBT3 EXPRESSION TAG SEQRES 1 A 210 SER ASN ALA LEU THR PRO ALA GLU VAL SER ALA VAL CYS SEQRES 2 A 210 GLU GLU LYS LYS LEU ASN VAL ALA HIS GLY LEU ALA TRP SEQRES 3 A 210 SER TYR TYR ILE GLY TYR LEU ARG LEU ILE LEU PRO GLY SEQRES 4 A 210 LEU GLN ALA ARG ILE ARG MET PHE ASN GLN LEU HIS ASN SEQRES 5 A 210 ASN MET LEU SER GLY ALA GLY SER ARG ARG LEU TYR ILE SEQRES 6 A 210 LEU PHE PRO LEU ASP CYS GLY VAL PRO ASP ASN LEU SER SEQRES 7 A 210 VAL VAL ASP PRO ASN ILE ARG PHE ARG ASP MET LEU PRO SEQRES 8 A 210 GLN GLN ASN ILE ASP ARG ALA GLY ILE LYS ASN ARG VAL SEQRES 9 A 210 TYR SER ASN SER VAL TYR GLU ILE LEU GLU ASN GLY GLN SEQRES 10 A 210 PRO ALA GLY VAL CYS ILE LEU GLU TYR ALA THR PRO LEU SEQRES 11 A 210 GLN THR LEU PHE ALA MET SER GLN ASP ALA LYS ALA GLY SEQRES 12 A 210 PHE SER ARG GLU ASP ARG LEU GLU GLN ALA LYS LEU PHE SEQRES 13 A 210 CYS ARG THR LEU GLU GLU ILE LEU GLU ASP VAL PRO GLU SEQRES 14 A 210 SER ARG ASN ASN CYS ARG LEU ILE VAL TYR GLN GLU PRO SEQRES 15 A 210 THR ASP GLY ASN SER PHE SER LEU SER GLN GLU VAL LEU SEQRES 16 A 210 ARG HIS ILE ARG GLN GLU GLU LYS GLU GLU VAL THR MET SEQRES 17 A 210 ASN ALA SEQRES 1 B 210 SER ASN ALA LEU THR PRO ALA GLU VAL SER ALA VAL CYS SEQRES 2 B 210 GLU GLU LYS LYS LEU ASN VAL ALA HIS GLY LEU ALA TRP SEQRES 3 B 210 SER TYR TYR ILE GLY TYR LEU ARG LEU ILE LEU PRO GLY SEQRES 4 B 210 LEU GLN ALA ARG ILE ARG MET PHE ASN GLN LEU HIS ASN SEQRES 5 B 210 ASN MET LEU SER GLY ALA GLY SER ARG ARG LEU TYR ILE SEQRES 6 B 210 LEU PHE PRO LEU ASP CYS GLY VAL PRO ASP ASN LEU SER SEQRES 7 B 210 VAL VAL ASP PRO ASN ILE ARG PHE ARG ASP MET LEU PRO SEQRES 8 B 210 GLN GLN ASN ILE ASP ARG ALA GLY ILE LYS ASN ARG VAL SEQRES 9 B 210 TYR SER ASN SER VAL TYR GLU ILE LEU GLU ASN GLY GLN SEQRES 10 B 210 PRO ALA GLY VAL CYS ILE LEU GLU TYR ALA THR PRO LEU SEQRES 11 B 210 GLN THR LEU PHE ALA MET SER GLN ASP ALA LYS ALA GLY SEQRES 12 B 210 PHE SER ARG GLU ASP ARG LEU GLU GLN ALA LYS LEU PHE SEQRES 13 B 210 CYS ARG THR LEU GLU GLU ILE LEU GLU ASP VAL PRO GLU SEQRES 14 B 210 SER ARG ASN ASN CYS ARG LEU ILE VAL TYR GLN GLU PRO SEQRES 15 B 210 THR ASP GLY ASN SER PHE SER LEU SER GLN GLU VAL LEU SEQRES 16 B 210 ARG HIS ILE ARG GLN GLU GLU LYS GLU GLU VAL THR MET SEQRES 17 B 210 ASN ALA HET 2BA A 401 44 HETNAM 2BA (2R,3R,3AS,5R,7AR,9R,10R,10AS,12R,14AR)-2,9-BIS(6- HETNAM 2 2BA AMINO-9H-PURIN-9-YL)OCTAHYDRO-2H,7H-DIFURO[3,2-D:3', HETNAM 3 2BA 2'-J][1,3,7,9,2,8 ]TETRAOXADIPHOSPHACYCLODODECINE-3,5, HETNAM 4 2BA 10,12-TETROL 5,12-DIOXIDE HETSYN 2BA BIS-(3',5')-CYCLIC-DIMERIC-ADENOSINE-MONOPHOSPHATE FORMUL 3 2BA C20 H24 N10 O12 P2 FORMUL 4 HOH *54(H2 O) HELIX 1 AA1 ASN A 153 GLY A 165 1 13 HELIX 2 AA2 TYR A 166 LEU A 171 1 6 HELIX 3 AA3 GLY A 173 HIS A 185 1 13 HELIX 4 AA4 GLY A 191 ARG A 195 5 5 HELIX 5 AA5 ASN A 210 ASP A 215 1 6 HELIX 6 AA6 THR A 262 ASP A 273 1 12 HELIX 7 AA7 SER A 279 GLU A 299 1 21 HELIX 8 AA8 SER A 323 GLU A 335 1 13 HELIX 9 AA9 VAL B 154 GLY B 165 1 12 HELIX 10 AB1 TYR B 166 LEU B 171 1 6 HELIX 11 AB2 GLY B 173 HIS B 185 1 13 HELIX 12 AB3 ASN B 210 ASP B 215 1 6 HELIX 13 AB4 THR B 262 ASP B 273 1 12 HELIX 14 AB5 SER B 279 LEU B 298 1 20 HELIX 15 AB6 GLU B 299 VAL B 301 5 3 HELIX 16 AB7 GLU B 303 ASN B 306 5 4 HELIX 17 AB8 SER B 323 GLN B 334 1 12 SHEET 1 AA1 5 ILE A 218 MET A 223 0 SHEET 2 AA1 5 SER A 242 GLU A 248 -1 O VAL A 243 N ASP A 222 SHEET 3 AA1 5 GLN A 251 TYR A 260 -1 O CYS A 256 N TYR A 244 SHEET 4 AA1 5 LEU A 197 PRO A 202 1 N LEU A 200 O GLU A 259 SHEET 5 AA1 5 CYS A 308 TYR A 313 1 O ARG A 309 N ILE A 199 SHEET 1 AA2 2 GLN A 227 ARG A 231 0 SHEET 2 AA2 2 ILE A 234 TYR A 239 -1 O ILE A 234 N ARG A 231 SHEET 1 AA3 5 ILE B 218 MET B 223 0 SHEET 2 AA3 5 SER B 242 GLU B 248 -1 O VAL B 243 N ASP B 222 SHEET 3 AA3 5 GLN B 251 TYR B 260 -1 O GLY B 254 N ILE B 246 SHEET 4 AA3 5 LEU B 197 PRO B 202 1 N LEU B 200 O GLU B 259 SHEET 5 AA3 5 CYS B 308 TYR B 313 1 O ILE B 311 N PHE B 201 SHEET 1 AA4 2 GLN B 227 ARG B 231 0 SHEET 2 AA4 2 ILE B 234 TYR B 239 -1 O ARG B 237 N ILE B 229 SITE 1 AC1 24 SER A 161 GLY A 165 TYR A 166 ILE A 234 SITE 2 AC1 24 ARG A 237 VAL A 238 TYR A 239 THR A 262 SITE 3 AC1 24 PRO A 263 HOH A 505 HOH A 511 HOH A 516 SITE 4 AC1 24 HOH A 520 SER B 161 GLY B 165 TYR B 166 SITE 5 AC1 24 ILE B 234 ARG B 237 VAL B 238 TYR B 239 SITE 6 AC1 24 THR B 262 PRO B 263 HOH B 403 HOH B 412 CRYST1 45.427 48.208 172.420 90.00 90.00 90.00 P 2 21 21 8 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.022013 0.000000 0.000000 0.00000 SCALE2 0.000000 0.020743 0.000000 0.00000 SCALE3 0.000000 0.000000 0.005800 0.00000